NCT04559126View on ClinicalTrials.gov

A Study of EDP-297 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

June 21, 2021

Study Completion Date

June 21, 2021

Conditions
NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis
Interventions
DRUG

EDP-297

EDP-297 Oral solution

DRUG

Placebo

placebo to match EDP-297

Trial Locations (1)

9728 NZ

PRA Health Sciences, Groningen

Sponsors

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Enanta Pharmaceuticals, Inc

INDUSTRY

NCT04559126 - A Study of EDP-297 in Healthy Subjects | Biotech Hunter | Biotech Hunter